Jin Xiaotao, deputy director of the National Health and Family Planning Commission, said today that in recent years, the annual growth rate of the IT market in China's health care industry has remained above 14%, and the growth rate of the mobile medical market has reached more than 20%. It has already developed a wealth of health care big data application development practice. . The State Council Information Office held a briefing on the policy of the State Council today. There were reporters asking questions to promote and standardize the application and development of medical big data. What is the significance for industry and enterprises? In this regard, Jin Xiaotao pointed out that relevant research shows that in recent years, the annual growth rate of the IT market in China's healthcare industry has remained above 14%, and the growth rate of the mobile medical market has reached more than 20%. It has already enriched the development practice of health medical big data applications. It is forming a working foundation for accelerating development. Data map Hong Jianpeng photo Jin Xiaotao said that in terms of industrial development, the future health care industry will contribute more and more to the national economy. There are more than 20 departments involved in the Guiding Opinions, covering almost all major industry sectors, including medical services, health management, and food (food hygiene), including the environment, pension insurance, and medical care. GMP ATS Injection, Tetanus Antitoxin, Tetanus Toxoid ,Tetanus Antitoxin Injection, Antitetanus, Refined Tetanus Antitoxinsupplier in China Tetanus Antitoxin,Tetanus Toxoid,Tetanus Antitoxin Injection,Antitetanus&Refined Tetanus Antitoxin FOSHAN PHARMA CO., LTD. , https://www.fs-pharma.com
Health Planning Commission: China Mobile Medical Market grows by more than 20%